Synergistic effect of hypoxia and tumor necrosis factor-α on the production of plasminogen activator inhibitor-1 (PAI-1) in human proximal renal tubular cells (HPTC).

被引：0
|
作者：
Li, X
Kimura, H
Hirota, K
Kasuno, K
Torii, K
Okada, T
Yodoi, J
Yoshida, H
机构：
[1] Fukui Med Univ, Dept Lab Med & Nephrol, Fukui, Japan
[2] Natl Inst AIST, Human Stress Signal Ctr, BioMed Special Res Unit, Osaka, Japan
[3] Kyoto Univ, Inst Virus Res, Dept Biol Responses, Kyoto, Japan
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：172A / 172A
页数：1
相关论文
共 50 条
  • [31] Production of Urokinase-Type Plasminogen Activator (u-PA) and Plasminogen Activator Inhibitor-1 (PAI-1) in Human Brain Tumours
    Y. Arai
    T. Kubota
    T. Nakagawa
    M. Kabuto
    K. Sato
    H. Kobayashi
    Acta Neurochirurgica, 1998, 140 : 377 - 386
  • [32] Production of urokinase-type plasminogen activator (u-PA) and plasminogen activator inhibitor-1 (PAI-1) in human brain tumours
    Arai, Y
    Kubota, T
    Nakagawa, T
    Kabuto, M
    Sato, K
    Kobayashi, H
    ACTA NEUROCHIRURGICA, 1998, 140 (04) : 377 - 386
  • [33] Generation and characterization of endothelial cells transduced with plasminogen activator inhibitor-1 (PAI-1) or vitronectin
    Schar, CR
    Sackman, JE
    Peterson, CB
    THROMBOSIS AND HAEMOSTASIS, 1999, : 810 - 810
  • [34] DAYTIME FLUCTUATIONS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) IN POPULATIONS WITH HIGH PAI-1 LEVELS
    JUHANVAGUE, I
    ALESSI, MC
    RACCAH, D
    AILLAUD, MF
    BILLEREY, M
    ANSALDI, J
    PHILIPJOET, C
    VAGUE, P
    THROMBOSIS AND HAEMOSTASIS, 1992, 67 (01) : 76 - 82
  • [35] Plasminogen activator inhibitor-1 (PAI-1) is anti-fibrogenic in human inflammatory cardiomyopathy
    Baumeier, C.
    Escher, F.
    Pietsch, H.
    Aleshcheva, G.
    Schultheiss, H. P.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1729 - 1729
  • [36] Plasminogen activator inhibitor-1 (PAI-1) - pathogenetic role in coronary disease
    Mlynarska, Agata
    Waszyrowski, Tomasz
    Kasprzak, Jaroslaw D.
    KARDIOLOGIA POLSKA, 2007, 65 (09) : 1109 - 1114
  • [37] PURIFICATION AND CHARACTERIZATION OF NATURAL AND RECOMBINANT HUMAN-PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1)
    ALESSI, MC
    DECLERCK, PJ
    DEMOL, M
    NELLES, L
    COLLEN, D
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1988, 175 (03): : 531 - 540
  • [38] Effect of troglitazone on plasminogen activator inhibitor on (PAI-1)
    Fonseca, V
    Reynolds, T
    Hemphill, D
    Randolph, C
    Valiquett, T
    Graveline, J
    Fink, L
    DIABETOLOGIA, 1997, 40 : 1616 - 1616
  • [39] Inactivation of plasminogen activator inhibitor-1 (PAI-1) by XR5118
    Faint, R
    Charlton, P
    Templeton, D
    Bent, F
    Folkes, A
    Mackie, I
    Machin, S
    Bevan, P
    BLOOD, 1996, 88 (10) : 1121 - 1121
  • [40] REACTIVATION OF LATENT PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) INVIVO
    VAUGHAN, DE
    DECLERCK, PJ
    VANHOUTTE, E
    DEMOL, M
    COLLEN, D
    ARTERIOSCLEROSIS, 1990, 10 (05): : A909 - A909
12345